Sapropterin As a Treatment for Autistic Disorder: A Randomized, Double-Blind, Placebo-Controlled Trial


Please note that this schedule is subject to change. The Program Book distributed at the Annual Meeting will have final information on dates, times, and speakers for each presentation.

New Research Poster Presentation 2.39
Sapropterin As a Treatment for Autistic Disorder: A Randomized, Double-Blind, Placebo-Controlled Trial

Thursday, October 20, 2011

Glen R. Elliott, M.D., Ph.D., Children's Health Council, Palo Alto, CA

Cheryl Klaiman, Ph.D., Clinical Services, Children's Health Council, Palo Alto, CA

Lauren M. Masaki, B.A., Evaluation and Quality Improvement, Children's Health Council, Palo Alto, CA

Lynne C. Huffman, M.D., Pediatrics, Stanford University, Palo Alto, CA